Kevin P. Starr, 10% Owner at CytomX Therapeutics, Inc. (CTMX), sold 56,714 shares at $16.36 ($928K) on 2017-04-12, disclosed to the SEC on 2017-04-14.
Open-market sale of $928k CTMX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.36 | 28,357 | $464K | 50.0% |
| 2 | $16.36 | 28,357 | $464K | 50.0% |
| Total | $16.36 avg | 56,714 | $928K | 100% |
| Filing → |
| FULC | BUY | 2019-07-22 | $1.3M | — | Filing → |
| SAGE | SELL | 2018-04-19 | $10.0M | — | Filing → |
| MYOK | SELL | 2018-01-05 | $34.3M | — | Filing → |